Loading clinical trials...
Loading clinical trials...
An Open-label, Multicenter Phase Ib/2a Study of TEW-7197 (Vactosertib) Plus Weekly Paclitaxel As Second-line Treatment for Metastatic Gastric Adenocarcinoma
Conditions
Interventions
TEW-7197
Locations
6
South Korea
Hallym University Medical Center
Anyang-si, South Korea
Hwasun Chunnam university hospital
Hwasun, South Korea
Chung-Ang University hospital
Seoul, South Korea
Gangbuk Samsung Medical Center
Seoul, South Korea
Gangnam Severance
Seoul, South Korea
Shinchon Severance
Seoul, South Korea
Start Date
August 15, 2018
Primary Completion Date
January 3, 2022
Completion Date
December 28, 2022
Last Updated
December 9, 2024
NCT07102901
NCT06768463
NCT06773312
NCT05714124
NCT06177041
NCT02065765
Lead Sponsor
MedPacto, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions